Hyperprolactinemia

Last updated: April 22, 2021

Hyperprolactinemia

Watch later

Watch later

Complement deficiency
Complement system
Glycogen metabolism
Gluconeogenesis
Fatty acid synthesis
Fatty acid oxidation
Antibody classes
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
B-cell activation, differentiation, and contraction
T-cell activation
B-cell development
Monoclonal antibodies
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Iron deficiency anemia
Sideroblastic anemia
Microcytic anemia: Pathology review
Macrocytic anemia: Pathology review
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Anemia of chronic disease
Alpha-thalassemia
Beta-thalassemia
Platelet plug formation (primary hemostasis)
Clot retraction and fibrinolysis
Disseminated intravascular coagulation
Von Willebrand disease
Heparin-induced thrombocytopenia
Thrombotic thrombocytopenic purpura
Hemolytic-uremic syndrome
Immune thrombocytopenia
Coagulation disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Platelet disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Hemophilia
Adrenal gland histology
Pheochromocytoma
Pituitary gland histology
Cushing syndrome
Hyperprolactinemia
Prolactinoma
Pituitary adenoma
Sheehan syndrome
Growth hormone deficiency
Primary adrenal insufficiency
Hyperaldosteronism
Cortisol
Synthesis of adrenocortical hormones
Diabetes mellitus
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Glucagon
Insulin
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperthyroidism: Pathology review
Hypopituitarism: Pathology review
Hypothyroidism: Pathology review
Multiple endocrine neoplasia: Pathology review
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Ascending and descending spinal tracts
Blood brain barrier
Cerebral circulation
Cerebrospinal fluid
Cranial nerves
Nervous system anatomy and physiology
Neuron action potential
Adrenergic receptors
Sympathetic nervous system
Cholinergic receptors
Parasympathetic nervous system
Enteric nervous system
Motor cortex
Muscle spindles and golgi tendon organs
Pyramidal and extrapyramidal tracts
Sensory receptor function
Somatosensory pathways
Somatosensory receptors
Anatomy of the male reproductive organs of the pelvis
Nerves and lymphatics of the pelvis
Estrogen and progesterone
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review

Transcript

Watch video only

With hyperprolactinemia, hyper- means above, -prolactin refers to the hormone produced by the pituitary gland, and -emia refers to the blood, so hyperprolactinemia means higher than normal prolactin levels in the blood.

Normally, at the base of the brain, there’s a small pea-sized gland called the pituitary gland.

The anterior pituitary - the front of the pituitary gland - has a number of different cells, each of which secretes a different hormone.

One group, the lactotroph cells, secrete prolactin. In men, excess prolactin decreases testosterone production.

In women, during pregnancy, elevated levels of estrogen stimulate the lactotrophs to produce large amounts of prolactin which stimulates alveolar cells in the breasts.

In response to prolactin, the alveolar cells divide and enlarge - and once a baby is born, lactogenesis begins - which means that milk is produced.

Apart from milk production, high levels of prolactin also inhibit the release of gonadotropin releasing hormone from the hypothalamus, which results in decreased luteinizing and follicle stimulating hormone levels, which in turn, decreases estrogen levels.

In women, this can stop ovulation and menstruation, which is why women typically don’t have a menstrual period while breastfeeding. In women that are not pregnant or breastfeeding, and in men, prolactin levels are usually kept in check by the hypothalamus in two ways.

The first way is the most important, and it’s when the hypothalamus secretes a constant stream of dopamine which is also called prolactin inhibiting factor.

Dopamine binds to specific receptors on the lactotrophs and inhibits the release of prolactin. The second way is when the hypothalamus secretes thyrotropin releasing hormone, also called prolactin releasing hormone, which can stimulate prolactin release.

If the level of prolactin rises for any reason, then it signals the hypothalamus to release more dopamine, eventually decreasing its own production, a process called negative feedback or feedback inhibition.

Hyperprolactinemia can develop a few different ways. The first is physiologic hyperprolactinemia, which is what happens during pregnancy and lactation - and levels of prolactin typically return back to normal afterwards.

Another cause is a prolactinoma, a type of pituitary adenoma, a benign tumor of lactotroph cells which grow uncontrollably and make excess amounts of prolactin. There are also systemic causes of hyperprolactinemia like hypothyroidism.

In hypothyroidism, the hypothalamus tries to boost the production of thyroid hormones by releasing more thyrotropin releasing hormone. That leads to higher levels of prolactin.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  5. "Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia" Taiwanese Journal of Obstetrics and Gynecology (2017)
  6. "Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia" Neuroendocrinology (2019)